Related Experiment Video
Updated: Aug 23, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
[Dyslipidemia]
1Institute of Clinical Medicine, University of Tsukuba.
Abstract:
Metabolic syndrome has been proposed to indicate individuals in whom the coexistence of three or more factors with obesity or insulin resistance precipitates ischemic cardiac disease, although each individual risk factor is not severe when taken into consideration separately. Reaven used the term 'syndrome X' to indicate cases in whom hyperinsulinemia, IGT, low blood HDL(high-density lipoprotein)-cholesterol level, high blood VLDL(very low density lipoprotein) triglyceride level, and hypertension are all present. Visceral fat syndrome caused by accumulation of visceral fat has also been proposed. These conditions are accompanied by certain concomitant risk factors such as obesity, hypenutrition, insufficient exercise, and genetic predisposition, and are related to insulin resistance. A decrease in triglyceride degradation by lipoprotein lipase due to insulin resistance leads to an increase in remnant particles and a decrease in HDL.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipid Digestion
Atherosclerosis III: Management